Parexel International (PRXL) Inactive 10-Q2 May 142014 Q3 Quarterly reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
Document And Entity Information	Mar. 31, 2014	Apr. 30, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'PAREXEL INTERNATIONAL CORP	'
Entity Central Index Key	'0000799729	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	56,875,405

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Jun. 30, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Jun. 30, 2013
ASSETS	'	'
Cash and cash equivalents	$298,655	$144,027
Marketable Securities, Current	0	130,137
Billed and unbilled accounts receivable, net	751,869	705,374
Prepaid expenses	21,134	19,358
Deferred tax assets	49,403	44,236
Income taxes receivable	0	4,071
Other current assets	46,620	30,254
Total current assets	1,167,681	1,077,457
Property and equipment, net	228,207	224,225
Goodwill	326,295	319,478
Other intangible assets, net	94,620	103,514
Non-current deferred tax assets	9,816	8,556
Long-term income taxes receivable	10,461	11,153
Other assets	36,205	35,241
Total assets	1,873,285	1,779,624
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Notes payable and current portion of long-term debt	10,533	20,399
Accounts payable	56,839	54,232
Deferred revenue	456,393	378,950
Accrued expenses	48,629	42,211
Accrued employee benefits and withholdings	163,575	149,290
Current deferred tax liabilities	22,281	16,512
Taxes Payable, Current	5,534	0
Other current liabilities	6,812	12,634
Total current liabilities	770,596	674,228
Long-term debt, net of current portion	286,748	424,074
Non-current deferred tax liabilities	27,345	35,443
Long-term income tax liabilities	44,282	45,183
Long-term deferred revenue	38,389	29,386
Other liabilities	35,161	32,364
Total liabilities	1,202,521	1,240,678
Stockholders' equity:	'	'
Preferred stock	0	0
Common stock	569	563
Additional paid-in capital	129,555	113,771
Retained earnings	543,672	454,650
Accumulated other comprehensive (loss) income	-3,032	-30,038
Total stockholders' equity	670,764	538,946
Total liabilities and stockholders' equity	$1,873,285	$1,779,624

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets Parenthethical (USD $)	Mar. 31, 2014	Jun. 30, 2013
Preferred Stock, Par or Stated Value Per Share	$0.01	$0.01
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$0.01	$0.01
Common Stock, Shares Authorized	150,000,000	150,000,000
Common Stock, Shares, Outstanding	56,851,510	56,310,582

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Revenues [Abstract]	'	'	'	'
Service revenue	$492,375	$454,493	$1,428,765	$1,271,314
Reimbursement revenue	85,543	68,958	252,453	197,794
Total revenue	577,918	523,451	1,681,218	1,469,108
Costs and Expenses [Abstract]	'	'	'	'
Direct costs	323,149	311,917	950,850	892,646
Reimbursable out-of-pocket expenses	85,543	68,958	252,453	197,794
Selling, general and administrative	96,602	88,038	277,042	229,975
Depreciation	16,802	15,773	48,848	46,030
Amortization of Intangible Assets	3,725	2,891	11,383	6,018
Restructuring (benefit) charges	-74	-732	-74	-1,150
Total costs and expenses	525,747	486,845	1,540,502	1,371,313
Income from operations	52,171	36,606	140,716	97,795
Interest Income (Expense), Net	-2,072	-2,586	-7,342	-5,423
Miscellaneous income (expense)	-292	1,813	-1,694	2,053
Total other expense	-2,364	-773	-9,036	-3,370
Income before income taxes	49,807	35,833	131,680	94,425
Provision for income taxes	15,068	6,309	42,658	28,494
Net income	$34,739	$29,524	$89,022	$65,931
Earnings per common share	'	'	'	'
Basic	$0.61	$0.51	$1.58	$1.12
Diluted	$0.60	$0.50	$1.55	$1.10
Shares used in computing earnings per common share	'	'	'	'
Basic	56,713	58,024	56,494	58,942
Diluted	57,673	59,074	57,486	60,005

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Net Income (Loss) Attributable to Parent	$34,739	$29,524	$89,022	$65,931
Unrealized gain on derivative instruments, net of taxes	-176	-1,067	4,750	-1,117
Foreign currency translation adjustment	-686	-15,339	22,256	4,861
Total comprehensive income	$33,877	$13,118	$116,028	$69,675

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flow from operating activities:	'	'
Net Income (Loss) Attributable to Parent	$89,022	$65,931
Depreciation and amortization	60,231	52,048
Share-based Compensation	10,880	8,103
Excess Tax Benefit from Share-based Compensation, Operating Activities	-3,467	-3,830
Deferred income taxes	-11,927	8,262
Other Noncash (Income) Expense	-134	-529
Changes in operating assets and liabilities	44,094	21,752
Net cash provided by (used in) operating activities:	188,699	151,737
Cash flow from investing activities:	'	'
Payments to Acquire Businesses, Net of Cash Acquired	-150	-74,731
Payments to Acquire Marketable Securities	-154,691	-182,316
Proceeds from Sale and Maturity of Marketable Securities	291,824	91,791
Purchases of property and equipment	-49,730	-50,101
Proceeds from Sale of Property, Plant, and Equipment	0	1,670
Proceeds from Collection of Notes Receivable	0	659
Net cash used in investing activities	87,253	-213,028
Cash flow from financing activities:	'	'
(Payments) proceeds from issuance of common stock	3,869	12,054
Payments for Repurchase of Common Stock	-4,906	-150,032
Excess Tax Benefit from Share-based Compensation, Financing Activities	3,467	3,830
Borrowing under credit agreement/facility	345,000	595,000
Repayments of Lines of Credit	-482,500	-415,000
Proceeds under factoring agreement	4,497	0
Payments of Financing Costs	-671	-1,231
Net cash (used in) provided by financing activities	-131,244	44,621
Effect of exchange rate changes on cash and cash equivalents	9,920	1,704
Net increase (decrease) in cash and cash equivalents	154,628	-14,966
Cash and cash equivalents at beginning of period	144,027	213,579
Cash and cash equivalents at end of period	298,655	198,613
Supplemental disclosures of cash flow information	'	'
Non-cash debt settlement under factoring agreement	14,359	0
Interest	10,957	7,261
Income taxes, net of refunds	$44,775	$30,369

Basis_Of_Presentation

Basis Of Presentation	9 Months Ended
Basis Of Presentation	Mar. 31, 2014
Basis Of Presentation [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements of PAREXEL International Corporation (“PAREXEL,” the “Company,” “we,” “our” or “us”) have been prepared in accordance with generally accepted accounting principles for interim financial information in the United States and the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (primarily consisting of normal recurring adjustments) considered necessary for a fair presentation of the Company’s financial position and results of operations as of March 31, 2014 and for the three and nine months ended March 31, 2014 and 2013 have been included. Operating results for the three and nine months ended March 31, 2014 are not necessarily indicative of the results that may be expected for other quarters or the entire fiscal year. For further information, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013 (the “2013 10-K”) filed with the Securities and Exchange Commission on August 22, 2013.
	Net Presentation Adjustment
	We have a cash pooling arrangement with RBS Nederland, NV. Pooling occurs when debit balances are offset against credit balances and the overall net position is used as a basis by the bank for calculating the overall pool interest amount. Each legal entity owned by us and party to this arrangement remains the owner of either a credit (deposit) or a debit (overdraft) balance. Therefore, interest income is earned by legal entities with credit balances, while interest expense is charged to legal entities with debit balances. Based on the pool’s aggregate balance, the bank then (1) recalculates the overall interest to be charged or earned, (2) compares this amount with the sum of previously charged/earned interest amounts per account and (3) additionally pays/charges the difference.
	We adjusted the presentation for interest income and interest expense in our results of operation for the three and nine months ended March 31, 2013. We determined a net presentation of either interest expense or interest income better reflects the impact on our results of operations for the cash pooling arrangement (see Note 8) compared to our prior practice of reporting interest income and expense on a gross basis. For the three and nine months ended March 31, 2013, we incurred net interest expense on our cash pooling arrangement, and therefore we netted the previously reported interest income of $0.8 million against the interest expense of $3.4 million for the three months ended March 31, 2013 and interest income of $2.9 million against the interest expense of $8.3 million for the nine months ended March 31, 2013. This adjustment had no impact on our consolidated financial positions for June 30, 2013 or our consolidated statement of cash flow for the nine months ended March 31, 2013.
	Recently Implemented Accounting Standards
	In December 2011, the Financial Accounting Standard Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2011-11, “Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities.” ASU 2011-11 requires a company to disclose information about offsetting and related arrangements to enable readers of its financial statements to understand the effects of those arrangements on its financial position. ASU 2011-11 is effective for fiscal years beginning after January 1, 2013. In January 2013, the FASB issued ASU No. 2013-01, “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities.” ASU 2013-01 was issued to limit the scope of ASU 2011-11 to derivatives (including bifurcated embedded derivatives), repurchase and reverse repurchase arrangements, and securities borrowing and lending transactions. We adopted ASU 2013-01 beginning in our fiscal quarter ended September 30, 2013. The adoption of ASU 2013-01 did not impact our consolidated financial statements.
	In February 2013, the FASB issued ASU No. 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” ASU 2013-02 requires reporting and disclosure about changes in accumulated other comprehensive income (AOCI) balances and reclassifications out of AOCI. We adopted ASU 2013-02 beginning in our fiscal quarter ended September 30, 2013. The adoption of ASU 2013-02 did not impact our consolidated financial statements.
	Recently Issued Accounting Standards
	In March 2013, the FASB issued ASU No. 2013-05, “Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity.” ASU 2013-05 addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. ASU 2013-05 is effective prospectively for fiscal years and interim periods within those fiscal years beginning after December 15, 2013 and early adoption is permitted. We do not expect the adoption of this guidance to have a material impact on our consolidated financial statements.
	In July 2013, the FASB issued ASU No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU 2013-11 requires that entities present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset in the financial statements for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years beginning after December 15, 2013, however early adoption and retrospective application is permitted. We do not expect the adoption of this guidance to have a material impact on our consolidated financial statements.

Equity_and_Earnings_Per_Share

Equity and Earnings Per Share	9 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Equity and Earnings Per Share	'
	EQUITY AND EARNINGS PER SHARE
	We have authorized five million shares of preferred stock at $0.01 par value. As of March 31, 2014 and June 30, 2013, we had no shares of preferred stock issued and outstanding.
	We have authorized 150 million shares of common stock at $0.01 par value. As of March 31, 2014 and June 30, 2013, we had 56,851,510 and 56,310,582 shares of common stock issued and outstanding, respectively.
	We compute basic earnings per share by dividing net income for the period by the weighted average number of common shares outstanding during the period. We compute diluted earnings per share by dividing net income by the weighted average number of common shares plus the dilutive effect of outstanding stock options and restricted stock awards and units. The following table outlines the basic and diluted earnings per share computations:


	(in thousands, except per share data)	Three Months Ended				Nine Months Ended

		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013

	Net income attributable to common stock	$	34,739	$	29,524	$	89,022	$	65,931

	Weighted average number of shares outstanding, used in computing basic earnings per share	56,713		58,024		56,494		58,942

	Dilutive common stock equivalents	960		1,050		992		1,063

	Weighted average number of shares outstanding used in computing diluted earnings per share	57,673		59,074		57,486		60,005

	Basic earnings per share	$	0.61	$	0.51	$	1.58	$	1.12

	Diluted earnings per share	$	0.6	$	0.5	$	1.55	$	1.1

	Anti-dilutive equity instruments (excluded from the calculation of diluted earnings per share)	798		717		439		396

	Share Repurchase Plan
	In August 2012, our Board of Directors approved a share repurchase program (the “Program”) authorizing the repurchase of up to $200.0 million of our common stock to be financed with cash on hand, cash generated from operations, existing credit facilities, or new financing. During the fiscal year ended June 30, 2013, we repurchased $197.6 million of our common stock. We repurchased the remaining $2.4 million of our common stock in July 2013. The Program repurchases were effected pursuant to two separate $50.0 million accelerated share repurchase agreements (“ASR Agreements”) and two separate $50.0 million open market agreements (“Open Market Agreements”) entered into in September 2012 and March 2013. Pursuant to the Program, we repurchased 5,458,285 shares of our common stock at an average price of $36.64 per share from September 2012 to July 2013. The buyback activity also resulted in a reduction of our stockholders’ equity of $200.0 million for the value of shares that we repurchased and retired.
	In July 2013, we purchased 51,071 shares under our March 2013 Open Market Agreement and received 101,247 shares representing the final settlement of our March 2013 ASR Agreement. With the completion of our March 2013 Open Market Agreement and the final settlement of the March 2013 ASR Agreement, the Program was completed. No further share repurchases have been authorized by our Board of Directors as of the date of this Quarterly Report on Form 10-Q.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income	9 Months Ended
	Mar. 31, 2014
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'
Comprehensive Income	'
	COMPREHENSIVE INCOME
	The following table reflects the activity for the components of accumulated other comprehensive income, net of tax, for the nine months ended March 31, 2014:


	(in thousands)	Foreign Currency			Unrealized Gain/Loss on Derivatives			Total
	Balance as of June 30, 2013	$	(29,138	)	$	(900	)	$	(30,038	)
	Other comprehensive income before reclassifications	22,256			4,562			26,818

	Loss reclassified from accumulated other comprehensive income	—			188			188

	Net current-period other comprehensive income	$	22,256		$	4,750		$	27,006

	Balance at March 31, 2014	$	(6,882	)	$	3,850		$	(3,032	)

	The details regarding pre-tax gain (loss) on derivative instruments reclassified to net income from accumulated other comprehensive income for the three and nine months ended March 31, 2014 and 2013 are presented below:


		Three Months Ended						Affected Line in the Consolidated Statements of Income
	(in thousands)	March 31, 2014			March 31, 2013
	Interest rate contracts	$	(440	)	$	(296	)	Interest expense, net
	Foreign exchange contracts	1,366			(959		)	Direct Costs

	Cross-currency swap contracts	—			—			Miscellaneous (expense) income, net

	Total	$	926		$	(1,255	)



		Nine Months Ended						Affected Line in the Consolidated Statements of Income
	(in thousands)	March 31, 2014			March 31, 2013
	Interest rate contracts	$	(1,308	)	$	(867	)	Interest expense, net
	Foreign exchange contracts	854			(630		)	Direct Costs

	Cross-currency swap contracts	114			218			Miscellaneous (expense) income, net

	Total	$	(340	)	$	(1,279	)
	The amounts of gain (loss) reclassified from accumulated other comprehensive income into net income are net of taxes of $0.4 million and $0.2 million for the three and nine months ended March 31, 2014, respectively.
	The amounts of gain (loss) reclassified from accumulated other comprehensive income into net income are net of taxes of $0.4 million and $0.5 million for the three and nine months ended March 31, 2013, respectively.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Mar. 31, 2014
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'
Stock-Based Compensation	'
	STOCK-BASED COMPENSATION
	We account for stock-based compensation according to FASB Accounting Standards Codification (“ASC”) 718, “Compensation—Stock Compensation.” The classification of compensation expense within the consolidated statements of income is presented in the following table:


	(in thousands)	Three Months Ended				Nine Months Ended
		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013
	Direct costs	$	878	$	531	$	2,212	$	1,310

	Selling, general and administrative	3,034		2,137		8,668		6,793

	Total stock-based compensation	$	3,912	$	2,668	$	10,880	$	8,103

Restructuring_Charges

Restructuring Charges

9 Months Ended

Mar. 31, 2014

Restructuring Charges [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING CHARGES

We have not adopted any plans in accordance with FASB ASC 420, “Exit or Disposal Cost Obligations,” to restructure our operations since the fiscal year ended June 30, 2012. The remaining accrued balances are for the restructuring plans adopted by us prior to June 30, 2012.

Current activity charged against restructuring accruals is presented in the following table.

(in thousands)

Balance at

Provisions/

Payments/Foreign

Balance at

June 30, 2013

Adjustments

Currency Exchange

March 31, 2014

Facilities-related charges and other

2,559

(74

)

(700

)

1,785

The balances are included in accrued expenses and other non-current liabilities in our condensed consolidated balance sheets.

Segment_Information

Segment Information	9 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	SEGMENT INFORMATION
	We have three reporting segments: Clinical Research Services (“CRS”), PAREXEL Consulting Services (“PC”), formerly known as PAREXEL Consulting and Medical Communication Services, and PAREXEL Informatics, Inc. (“PI”), formerly known as Perceptive Informatics, Inc.

	•	CRS constitutes our core business and includes all phases of clinical research from Early Phase (encompassing the early stages of clinical testing that range from first-in-man through proof-of-concept studies) to Phase II-III and Phase IV, which we call Peri/Post-Approval Services (“PACE”), formerly known as Peri Approval Clinical Excellence. Our services include clinical trials management and biostatistics, data management and clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacovigilance, and investigator site services. We aggregate Early Phase with Phase II-III/PACE due to economic similarities in these operating segments.

	•	PC provides technical expertise and advice in such areas as drug development, regulatory affairs, product pricing and reimbursement, commercialization and strategic compliance. It also provides a full spectrum of market development, product development, and targeted communications services in support of product launch. Our PC consultants identify alternatives and propose solutions to address client issues associated with product development, registration, and commercialization.

	•	PI provides information technology solutions designed to help improve clients’ product development and regulatory submission processes. PI offers a portfolio of products and services that includes medical imaging services, ClinPhone® randomization and trial supply management (“RTSM”), IMPACT® clinical trials management systems (“CTMS”), DataLabs® electronic data capture (“EDC”), web-based portals, systems integration, electronic patient reported outcomes (“ePRO”), and LIQUENT InSight® Regulatory Information Management solutions. These services are often bundled together and integrated with other applications to provide eClinical solutions for our clients.
	We evaluate our segment performance and allocate resources based on service revenue and gross profit (service revenue less direct costs), while other operating costs are allocated and evaluated on a geographic basis. Accordingly, we do not include the impact of selling, general, and administrative expenses, depreciation and amortization expense, other income (expense), and income tax expense in segment profitability. We attribute revenue to individual countries based upon the revenue earned in the respective countries; however, inter-segment transactions are not included in service revenue. Furthermore, we have a global infrastructure supporting our business segments, and therefore do not identify assets by reportable segment.
	Our segment results are as follows:


	(in thousands)	Three Months Ended				Nine Months Ended
		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013
	Service revenue
	CRS	$	373,216	$	342,387	$	1,069,675	$	960,134

	PC	51,880		50,611		160,949		148,236

	PI	67,279		61,495		198,141		162,944

	Total service revenue	$	492,375	$	454,493	$	1,428,765	$	1,271,314

	Direct costs
	CRS	$	255,244	$	246,882	$	748,663	$	709,463

	PC	30,420		30,424		94,909		88,563

	PI	37,485		34,611		107,278		94,620

	Total direct costs	$	323,149	$	311,917	$	950,850	$	892,646

	Gross profit
	CRS	$	117,972	$	95,505	$	321,012	$	250,671

	PC	21,460		20,187		66,040		59,673

	PI	29,794		26,884		90,863		68,324

	Total gross profit	$	169,226	$	142,576	$	477,915	$	378,668

Income_Taxes

Income Taxes	9 Months Ended
Income Taxes	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	We determine our global provision for corporate income taxes in accordance with FASB ASC 740, “Income Taxes.” We recognize our deferred tax assets and liabilities based upon the effect of temporary differences between the book and tax basis of recorded assets and liabilities. Further, we follow a methodology in which we identify, recognize, measure and disclose in our financial statements the effects of any uncertain tax return reporting positions that we have taken or expect to take. The methodology is based on the presumption that all relevant tax authorities possess full knowledge of those tax reporting positions, as well as all of the pertinent facts and circumstances. Our quarterly effective income tax rate contains management’s estimates of our annual projected profitability in the various taxing jurisdictions in which we operate. Since the statutory tax rates differ in the jurisdictions in which we operate, changes in the distribution of profits and losses may have a significant impact on our effective income tax rate.
	As of March 31, 2014, we had $44.5 million of gross unrecognized tax benefits, of which $29.2 million would impact the effective tax rate if recognized. As of June 30, 2013, we had $46.6 million of gross unrecognized tax benefits, of which $31.0 million would impact the effective tax rate if recognized. The reserves for unrecognized tax positions primarily relate to exposures for income tax matters such as changes in the jurisdiction in which income is taxable. The $2.1 million net decrease in gross unrecognized tax benefits is primarily attributable to a reduction resulting from the expiration of statutes of limitations in the United States, net of an increase attributable to currency translation adjustments.
	As of March 31, 2014, we anticipate that the liability for unrecognized tax benefits for uncertain tax positions could decrease by approximately $6.5 million over the next 12 months primarily as a result of the expiration of statutes of limitations and settlements with tax authorities. The potential decrease is primarily related to the jurisdiction in which income is taxable.
	We recognize interest and penalties related to income tax matters in income tax expense. As of March 31, 2014, $6.0 million of gross interest and penalties were included in the liability for unrecognized tax benefits. As of June 30, 2013, $5.0 million of gross interest and penalties were included in the liability for unrecognized tax benefits. For the nine months ended March 31, 2014 and 2013, an expense of $0.8 million and a benefit of $1.0 million, respectively, was recorded for interest and penalties related to tax matters.
	We are subject to U.S. federal income tax, as well as income tax in multiple state, local and foreign jurisdictions. All material U.S. federal and state and local income tax matters have been concluded with the respective taxing authority through 2005 and 2004, respectively. Substantially all material foreign income tax matters have been concluded for all years through 2000.
	For the three and nine months ended March 31, 2014, we had effective income tax rates of 30.3% and 32.4%, respectively. The tax rates for these periods were lower than the expected statutory rate of 35% primarily as a result of the favorable effect of a reduction in income tax reserves resulting from the expiration of statutes of limitations in the United States, offset by the effect of an increase in the statutory tax rate to which we are subject in China.
	For the three and nine months ended March 31, 2013, we had effective income tax rates of 17.6% and 30.2%, respectively. The tax rates for the three and nine months ended March 31, 2013 were lower than the statutory rate of 35% primarily as a result of the reinstatement of the “look-through” provision of the U.S. tax code effective January 2, 2013, as well as the favorable effect of statutory rates applicable to income earned outside the Unites States. These reductions were partially offset in the tax rate for the nine months ended March 31, 2013 by the limitation of certain compensation-related deductions. The tax rate for the three months ended March 31, 2013 was further reduced by a release of accrued interest and penalties on income tax reserves as a result of the expiration of statutes of limitations in Europe and Africa and a reduction in U.S. state deferred tax valuation allowances.

Credit_Agreements

Credit Agreements	9 Months Ended
	Mar. 31, 2014
Line of Credit Facility [Abstract]	'
Lines Of Credit	'
	Note Purchase Agreement
	On July 25, 2013, we issued $100.0 million principal amount of 3.11% senior notes due July 25, 2020 (the “Notes”) for aggregate gross proceeds of $100.0 million in a private placement solely to accredited investors. The Notes were issued pursuant to a Note Purchase Agreement entered into by us with certain institutional investors on June 25, 2013 (the “Note Purchase Agreement”). Proceeds from the Notes were used to pay down $100.0 million of principal borrowed under the revolving credit facility of the 2013 Credit Agreement, as described below. We will pay interest on the outstanding balance of the Notes at a rate of 3.11% per annum, payable semi-annually on January 25 and July 25 of each year until the principal on the Notes shall have become due and payable. We may, at our option, upon notice and subject to the terms of the Note Purchase Agreement, prepay at any time all or part of the Notes in an amount not less than 10% of the aggregate principal amount of the Notes then outstanding, plus a Make-Whole Amount (as defined in the Note Purchase Agreement). The Notes become due and payable on July 25, 2020, unless payment is required to be made earlier under the terms of the Note Purchase Agreement.
	The Note Purchase Agreement includes operational and financial covenants, with which we are required to comply, including, among others, maintenance of certain financial ratios and restrictions on additional indebtedness, liens and dispositions.
	In connection with the Note Purchase Agreement, certain of our subsidiaries entered into a Subsidiary Guaranty, pursuant to which such subsidiaries guaranteed our obligations under the Notes and the Note Purchase Agreement.
	As of March 31, 2014, we had $100.0 million of principal borrowed under the Note Purchase Agreement. The outstanding amounts are presented net of debt issuance cost of approximately $0.4 million in our consolidated balance sheets.
	Receivable Purchase Agreement
	On February 19, 2013, we entered into a receivables purchase agreement (the “Receivable Agreement”) with JPMorgan Chase Bank, N.A. (“JPMorgan”). Under the Receivable Agreement, we sell to JPMorgan or other investors on an ongoing basis certain of our trade receivables, together with ancillary rights and the proceeds thereof, which arise under contracts with a client, or its subsidiaries or affiliates. The Receivable Agreement includes customary representations and covenants on behalf of us, and may be terminated by either us or JPMorgan upon five business days advance notice. The Receivable Agreement provides a mechanism for accelerating the receipt of cash due on outstanding receivables. We account for the transfer of our receivables with respect to which we have satisfied the applicable revenue recognition criteria in accordance with FASB ASC 860, “Transfers and Servicing.” If we have not satisfied the applicable revenue recognition criteria for the underlying sales transaction, the transfer of the receivable is accounted for as a financing activity in accordance with FASB ASC 470, “Debt.” During the nine months ended March 31, 2014, we transferred approximately $122.9 million of trade receivables. As of March 31, 2014 and June 30, 2013, we accounted for $0.5 million and $10.4 million, respectively, of the total transfers as financing activities which are recorded in accounts receivable and short-term debt on our consolidated balance sheets. The accounts receivable and short-term debt balances are derecognized from our consolidated balance sheets at the earlier of the factored receivable’s due date or when all of the revenue recognition criteria are met for those billed services.
	2013 Credit Agreement
	On March 22, 2013, we, certain of our subsidiaries, Bank of America, N.A. (“Bank of America”), as Administrative Agent, Swingline Lender and L/C Issuer, Merrill Lynch, Pierce, Fenner & Smith Incorporated (“MLPFS”), J.P. Morgan Securities LLC (“JPM Securities”), HSBC Bank USA, National Association (“HSBC”) and U.S. Bank, National Association (“US Bank”), as Joint Lead Arrangers and Joint Book Managers, JPMorgan Chase Bank N.A. (“JPMorgan”), HSBC and US Bank, as Joint Syndication Agents, and the other lenders party thereto entered into an amended and restated credit agreement (the “2013 Credit Agreement”) providing for a five-year term loan of $200.0 million and a revolving credit facility in the amount of up to $300.0 million, plus additional amounts of up to $200.0 million of loans to be made available upon our request subject to specified terms and conditions. A portion of the revolving credit facility is available for swingline loans of up to a sublimit of $75.0 million and for the issuance of standby letters of credit of up to a sublimit of $10.0 million.

	On March 22, 2013, we drew down $107.5 million under the 2013 Credit Agreement and used the proceeds of the borrowing (i) to repay outstanding amounts under our existing four short-term credit facilities with each of Bank of America, HSBC, TD Bank, N.A. and US Bank (collectively, the “Short Term Credit Facilities”), (ii) for stock repurchases and (iii) for other general corporate purposes.
	As of March 31, 2014, we had $10.0 million of principal borrowed under the revolving credit facility and $190.0 million of principal borrowed under the term loan. The outstanding amounts are presented net of debt issuance cost of approximately $2.9 million in our consolidated balance sheets. As of March 31, 2014, we had borrowing availability of $290.0 million under the revolving credit facility.
	Our obligations under the 2013 Credit Agreement are guaranteed by certain of our material domestic subsidiaries, and the obligations, if any, of any foreign designated borrower are guaranteed by us and certain of our material domestic subsidiaries.
	Borrowings (other than swingline loans) under the 2013 Credit Agreement bear interest, at our determination, at a rate based on either (a) LIBOR plus a margin (not to exceed a per annum rate of 1.750%) based on a ratio of consolidated funded debt to consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) (the “Leverage Ratio”) or (b) the highest of (i) prime, (ii) the federal funds rate plus 0.50%, and (iii) the one month LIBOR rate plus 1.00% (such highest rate, the “Alternate Base Rate”), plus a margin (not to exceed a per annum rate of 0.750%) based on the Leverage Ratio. Swingline loans in U.S. dollars bear interest calculated at the Alternate Base Rate plus a margin (not to exceed a per annum rate of 0.750%).
	Loans outstanding under the 2013 Credit Agreement may be prepaid at any time in whole or in part without premium or penalty, other than customary breakage costs, if any, subject to the terms and conditions contained in the 2013 Credit Agreement. The 2013 Credit Agreement terminates and any outstanding loans under it mature on March 22, 2018 (the “Maturity Date”).
	Repayment of the principal borrowed under the revolving credit facility (other than a swingline loan) is due on the Maturity Date. Repayment of principal borrowed under the term loan facility is as follows, with the final payment of all amounts outstanding, plus accrued interest, being due on the Maturity Date:

	•	1.25% by quarterly term loan amortization payments to be made commencing June 2013 and made prior to June 30, 2015;

	•	2.50% by quarterly term loan amortization payments to be made on or after June 30, 2015, but prior to June 30, 2016;

	•	5.00% by quarterly term loan amortization payments to be made on or after June 30, 2016, but prior to June 30, 2017;

	•	7.50% by quarterly term loan amortization payment to be made on or after June 30, 2017, but prior to the Maturity Date; and

	•	37.50% on the Maturity Date
	Our obligations under the 2013 Credit Agreement may be accelerated upon the occurrence of an event of default, which includes customary events of default, including payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults relating to such matters as the Employee Retirement Income Security Act (ERISA) and judgments, and a change of control default.
	The 2013 Credit Agreement contains negative covenants applicable to us and our subsidiaries, including financial covenants requiring us to comply with maximum leverage ratios and minimum interest coverage ratios, as well as restrictions on liens, investments, indebtedness, fundamental changes, acquisitions, dispositions of property, making specified restricted payments (including stock repurchases exceeding an agreed to percentage of consolidated net income), and transactions with affiliates. As of March 31, 2014, we were in compliance with all covenants under the 2013 Credit Agreement.
	In connection with the 2013 Credit Agreement, we agreed to pay a commitment fee on the revolving loan commitment calculated as a percentage of the unused amount of the revolving loan commitment at a per annum rate of up to 0.350% (based on the Leverage Ratio). To the extent there are letters of credit outstanding under the 2013 Credit Agreement, we will pay letter of credit fees plus a fronting fee and additional charges. We also paid various customary fees to secure this arrangement, which are being amortized using the effective interest method over the life of the debt.
	In September 2011, we entered into an interest rate swap agreement and an interest rate cap agreement. Prior to the execution of the 2013 Credit Agreement, the interest rate swap and cap agreements hedged principal under our prior debt obligations. The interest rate swap agreement now hedges $100.0 million of principal under our 2013 Credit Agreement carrying a fixed interest rate of 1.30% plus an applicable margin. The interest rate cap agreement hedged $25.0 million of principal under our 2013 Credit Agreement with an interest rate cap of 2.00% plus an applicable margin. In March 2014, the interest rate cap agreement matured and the related accumulated other comprehensive income was reclassified to net income during the three months ended March 31, 2014.
	In May 2013, we entered into another interest rate swap agreement and hedged an additional principal amount of $100.0 million under the 2013 Credit Agreement with a fixed interest rate of 0.73% plus an applicable margin. As of March 31, 2014, our debt under the 2013 Credit Agreement, including the $200.0 million of principal hedged with both interest swap agreements, carried an average annualized interest rate of 2.02%. These interest rate hedges were deemed to be fully effective in accordance with FASB ASC 815, “Derivatives and Hedging” (“ASC 815”) and, as such, unrealized gains and losses related to these derivatives are recorded as other comprehensive income in our consolidated balance sheets.
	Additional Lines of Credit
	We have an unsecured line of credit with JP Morgan UK in the amount of $4.5 million that bears interest at an annual rate ranging between 2.00% and 4.00%. We entered into this line of credit to facilitate business transactions. At March 31, 2014, we had $4.5 million available under this line of credit.
	We have a cash pool facility with RBS Nederland, NV in the amount of 5.0 million Euros that bears interest at an annual rate ranging between 2.00% and 4.00%. We entered into this line of credit to facilitate business transactions. At March 31, 2014, we had 5.0 million Euros available under this line of credit.

Debt_Commitments_Contingencies

Debt, Commitments, Contingencies And Guarantees	9 Months Ended
	Mar. 31, 2014
Commitments, Contingencies And Guarantees [Abstract]	'
Commitments, Contingencies And Guarantees	'
	COMMITMENTS, CONTINGENCIES AND GUARANTEES
	Our future minimum debt obligations related to the instruments and agreements described in Note 8 above are as follows:


	(in thousands)	FY 2014		FY 2015		FY 2016		FY 2017		FY 2018		Thereafter		Total
	Debt obligations (principal)	$	3,033	$	12,500	$	25,000	$	45,000	$	115,000	$	100,000	$	300,533

	We have letter-of-credit agreements with banks totaling approximately $10.2 million guaranteeing performance under various operating leases and vendor agreements. Additionally, the borrowings under the 2013 Credit Agreement and Note Purchase Agreement are guaranteed by certain of our U.S. subsidiaries.
	We periodically become involved in various claims and lawsuits that are incidental to our business. We believe, after consultation with counsel, that no matters currently pending would, in the event of an adverse outcome, either individually or in the aggregate, have a material impact on our consolidated financial position, results of operations, or liquidity.

Derivatives

Derivatives	9 Months Ended
	Mar. 31, 2014
Summary of Derivative Instruments by Hedge Designation [Abstract]	'
Derivatives	'
	DERIVATIVES
	We are exposed to certain risks relating to our ongoing business operations. The primary risks managed by using derivative instruments are interest rate risk and foreign currency exchange rate risk. Accordingly, we have instituted interest rate and foreign currency hedging programs that are accounted for in accordance with ASC 815.

	•	Our interest rate hedging program is a cash flow hedge program designed to minimize interest rate volatility. We swap the difference between fixed and variable interest amounts calculated by reference to an agreed-upon notional principal amount, at specified intervals. We also employed an interest rate cap, which matured in March 2014, that compensates us if variable interest rates rise above a pre-determined rate. Our interest rate contracts are designated as hedging instruments.

	•	Our foreign currency hedging program is a cash flow hedge program designed to minimize foreign currency exchange rate volatility due to the foreign currency exchange exposure related to intercompany transactions. This program was expanded in the first quarter of the fiscal year ended June 30, 2013 in order to reduce the impact of foreign exchange rate risk on our gross margin. We primarily utilize forward currency exchange contracts and cross-currency swaps with maturities of no more than 12 months. These contracts are designated as hedging instruments.
	We also enter into other economic hedges to mitigate foreign currency exchange risk and interest rate risk related to intercompany and significant external transactions. These contracts are not designated as hedges in accordance with ASC 815.
	The following table presents the notional amounts and fair values of our derivatives as of March 31, 2014 and June 30, 2013. The gross position of all asset and liability amounts is reported in other current assets, other assets, other current liabilities, and other liabilities in our consolidated balance sheets.


	(in thousands)	March 31, 2014								June 30, 2013
		Notional				Asset				Notional				Asset
		Amount				(Liability)				Amount				(Liability)
	Derivatives designated as hedging instruments under ASC 815
	Derivatives in an asset position:
	Interest rate contracts	$	100,000			$	2,819			$	125,000			$	3,269

	Foreign exchange contracts	152,178				5,380				20,245				333

	Cross-currency swap contracts	25,760				1,125				27,312				1,032

	Derivatives in a liability position:
	Interest rate contracts	100,000				(1,719		)		100,000				(2,208		)

	Foreign exchange contracts	33,386				(964		)		129,254				(3,889		)

	Total designated derivatives	$	411,324			$	6,641			$	401,811			$	(1,463	)

	Derivatives not designated as hedging instruments under ASC 815
	Derivatives in an asset position:
	Foreign exchange contracts	$	50,016			$	995			$	20,756			$	91

	Derivatives in a liability position:
	Cross-currency interest rate swap contracts	—				—				44,580				(1,910		)

	Foreign exchange contracts	84,822				(429		)		42,800				(992		)

	Total non-designated derivatives	$	134,838			$	566			$	108,136			$	(2,811	)

	Total derivatives	$	546,162			$	7,207			$	509,947			$	(4,274	)

	We record the effective portion of any change in the fair value of derivatives designated as hedging instruments under ASC 815 to other accumulated comprehensive income (loss) in our consolidated balance sheets, net of deferred taxes, and any ineffective portion to miscellaneous (expense) income, net in our consolidated statements of income. During the three months ended March 31, 2014 and 2013, the amounts recorded in miscellaneous (expense) income, net in our consolidated statements of income to reflect ineffective portions of any hedges were a gain of $0.2 million and a loss of $0.5 million, respectively. During the nine months ended March 31, 2014 and 2013, the amounts recorded in miscellaneous (expense) income, net in our consolidated statements of income to reflect ineffective portions of any hedges were zero and a loss of $0.4 million, respectively.
	The amounts recognized in other comprehensive income (loss), net of taxes, are presented below:


	(in thousands)	Three Months Ended								Nine Months Ended
		March 31, 2014				March 31, 2013				March 31, 2014				March 31, 2013
	Derivatives designated as hedging instruments under ASC 815
	Interest rate contracts, net of taxes	$	195			$	155			$	152			$	281

	Foreign exchange contracts, net of taxes	10				(1,963		)		(4,987		)		(1,736		)

	Cross-currency swap contracts, net of taxes	(29		)		741				85				338

	Total designated derivatives	$	176			$	(1,067	)		$	(4,750	)		$	(1,117	)

	The unrealized gain (loss) on derivative instruments is net of $0.2 million and $3.1 million of taxes for the three and nine months ended March 31, 2014, respectively. The unrealized loss on derivative instruments is net of $0.7 million taxes for both the three and nine months ended March 31, 2013. The estimated net amount of the existing gains that are expected to be reclassified into earnings within the next twelve months is $3.3 million.
	The change in the fair value of derivatives not designated as hedging instruments under ASC 815 is recorded to miscellaneous (expense) income, net in our consolidated statements of income. The unrealized (loss) gain recognized are presented below:


	(in thousands)	Three Months Ended								Nine Months Ended
		March 31, 2014				March 31, 2013				March 31, 2014				March 31, 2013
	Derivatives not designated as hedging instruments under ASC 815
Cross-currency interest rate swap contracts	$	3,431			$	2,051			$	1,910			$	1,924

Foreign exchange contracts	736				(347		)		1,467				87

Total non-designated derivative unrealized (loss) gain, net	$	4,167			$	1,704			$	3,377			$	2,011

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	FAIR VALUE MEASUREMENTS
	We apply the provisions of FASB ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). ASC 820 defines fair value and provides guidance for measuring fair value and expands disclosures about fair value measurements. ASC 820 seeks to enable the reader of financial statements to assess the inputs used to develop those measurements by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. ASC 820 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

	•	Level 1 – Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.

	•	Level 2 – Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

	◦	quoted prices for similar assets and liabilities in active markets

	◦	quoted prices for identical or similar assets or liabilities in markets that are not active

	◦	observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate and yield curve quotes at commonly quoted intervals)

	◦	inputs that are derived principally from or corroborated by observable market data by correlation or other means

	•	Level 3 – Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).
	The following table sets forth by level, within the fair value hierarchy, our assets (liabilities) carried at fair value as of March 31, 2014:


	(in thousands)	Level 1				Level 2			Level 3			Total
	Contingent consideration	$	—			$	—		$	(5,883	)	$	(5,883	)
	Contingent consideration	$	—			$	—		$	(5,883	)	$	(5,883	)
	Interest rate derivative instruments	—				1,100			—			1,100
	Interest rate derivative instruments	—				1,100			—			1,100
	Foreign currency exchange contracts	—				6,107			—			6,107
	Foreign currency exchange contracts	—				6,107			—			6,107
	Total	$	—			$	7,207		$	(5,883	)	$	1,324
	Total	$	—			$	7,207		$	(5,883	)	$	1,324
	The following table sets forth by level, within the fair value hierarchy, our assets (liabilities) carried at fair value as of June 30, 2013:


	(in thousands)	Level 1				Level 2			Level 3			Total
	Contingent consideration	$	—			$	—		$	(5,934	)	$	(5,934	)
	Contingent consideration	$	—			$	—		$	(5,934	)	$	(5,934	)
	Interest rate derivative instruments	—				(849		)	—			(849		)
	Interest rate derivative instruments	—				(849		)	—			(849		)
	Foreign currency exchange contracts	—				(3,425		)	—			(3,425		)
	Foreign currency exchange contracts	—				(3,425		)	—			(3,425		)
	Total	$	—			$	(4,274	)	$	(5,934	)	$	(10,208	)
	Total	$	—			$	(4,274	)	$	(5,934	)	$	(10,208	)
	Cash equivalents are measured at quoted prices in active markets. These investments are considered cash equivalents due to the short maturity (less than 90 days) of the investments.
	Marketable securities are held in foreign government treasury certificates that are actively traded and have original maturities over 90 days but less than one year. As of March 31, 2014, we did not hold any marketable securities. As of June 30, 2013, we held marketable securities with a carrying value of $130.1 million. Our marketable securities are classified as held-to-maturity based on our intent and ability to hold the securities to maturity and are recorded at amortized cost, which is not materially different than fair value. Interest and dividends related to these securities are reported as a component of interest income in our consolidated statements of income.
	Interest rate derivative instruments are measured at fair value using a market approach valuation technique. The valuation is based on an estimate of net present value of the expected cash flows using relevant mid-market observable data inputs and based on the assumption of no unusual market conditions or forced liquidation.
	Foreign currency exchange contracts are measured at fair value using a market approach valuation technique. The inputs to this technique utilize current foreign currency exchange forward market rates published by leading third-party financial news and data providers. This is observable data that represent the rates that the financial institution uses for contracts entered into at that date; however, they are not based on actual transactions so they are classified as Level 2.
	On April 30, 2013, we acquired all of the outstanding equity securities of HERON Group LTD (“HERON”), a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. The net purchase price was approximately $22.8 million, plus the potential for us to pay up to an additional $14.2 million over a twenty-six month period if HERON achieves specific financial targets. We determined the fair value of the contingent consideration at the date of the acquisition to be $5.9 million.
	Contingent consideration related to the HERON acquisition is measured at fair value using an income approach valuation technique, specifically, with probability weighted and discounted cash flow methods. Increases or decreases in the fair value of our contingent consideration liability can result from changes in discount periods and rates, as well as the likelihood of achieving financial targets. The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs:


	Unobservable Input		Range
	Discount rate		18%
	Probability of achieving financial targets		10% to 45%
	Projected year of payment		2015

	The following table provides a summary of the change in our valuation of the fair value of the contingent consideration, which was determined by Level 3 inputs:


	(in thousands)		Fair Value
	Balance at June 30, 2013		$	5,934
	Balance at June 30, 2013		$	5,934
	Change in fair value related to contingent consideration from HERON acquisition		(51		)
	Balance at March 31, 2014		$	5,883
	Balance at March 31, 2014		$	5,883
	Contingent consideration liabilities are remeasured to fair value each reporting period using projected financial targets, discount rates, probabilities of payment and projected payment dates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model. Projected financial targets are based on our most recent internal operational budgets and long-range strategic plans. Increases in projected financial targets and probabilities of payment may result in higher fair value measurements. Increases in discount rates and the time to payment may result in lower fair value measurements. Increases or decreases in any of those inputs in isolation may result in a significantly lower or higher fair value measurement. For the nine months ended March 31, 2014, the change in fair value of contingent consideration of $0.1 million was recorded in selling, general and administrative expense.
For the nine months ended March 31, 2014, there were no transfers among Level 1, Level 2, or Level 3 categories. Additionally, there were no changes in the valuation techniques used to determine the fair values of our Level 2 or Level 3 assets or liabilities.
The fair value of the debt under Note Purchase Agreement was estimated to be $94.9 million as of March 31, 2014, and was determined using U.S. government treasury rates and Level 3 inputs, including a credit risk adjustment.
The carrying value of our short-term and long-term debt under the 2013 Credit Agreement approximates fair value because all of the debt bears variable rate interest.

Equity_and_Earnings_Per_Share_

Equity and Earnings Per Share (Tables)	9 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Computation Of Basic And Diluted Earnings Per Common Share	'


	(in thousands, except per share data)	Three Months Ended				Nine Months Ended

		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013

	Net income attributable to common stock	$	34,739	$	29,524	$	89,022	$	65,931

	Weighted average number of shares outstanding, used in computing basic earnings per share	56,713		58,024		56,494		58,942

	Dilutive common stock equivalents	960		1,050		992		1,063

	Weighted average number of shares outstanding used in computing diluted earnings per share	57,673		59,074		57,486		60,005

	Basic earnings per share	$	0.61	$	0.51	$	1.58	$	1.12

	Diluted earnings per share	$	0.6	$	0.5	$	1.55	$	1.1

	Anti-dilutive equity instruments (excluded from the calculation of diluted earnings per share)	798		717		439		396

Comprehensive_Income_Tables

Comprehensive Income (Tables)	9 Months Ended
	Mar. 31, 2014
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'
Schedule Of Comprehensive Income	'


	(in thousands)	Foreign Currency			Unrealized Gain/Loss on Derivatives			Total
	Balance as of June 30, 2013	$	(29,138	)	$	(900	)	$	(30,038	)
	Other comprehensive income before reclassifications	22,256			4,562			26,818

	Loss reclassified from accumulated other comprehensive income	—			188			188

	Net current-period other comprehensive income	$	22,256		$	4,750		$	27,006

	Balance at March 31, 2014	$	(6,882	)	$	3,850		$	(3,032	)

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)	'


		Nine Months Ended						Affected Line in the Consolidated Statements of Income
	(in thousands)	March 31, 2014			March 31, 2013
	Interest rate contracts	$	(1,308	)	$	(867	)	Interest expense, net
	Foreign exchange contracts	854			(630		)	Direct Costs

	Cross-currency swap contracts	114			218			Miscellaneous (expense) income, net

	Total	$	(340	)	$	(1,279	)


		Three Months Ended						Affected Line in the Consolidated Statements of Income
	(in thousands)	March 31, 2014			March 31, 2013
	Interest rate contracts	$	(440	)	$	(296	)	Interest expense, net
	Foreign exchange contracts	1,366			(959		)	Direct Costs

	Cross-currency swap contracts	—			—			Miscellaneous (expense) income, net

	Total	$	926		$	(1,255	)

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Mar. 31, 2014
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'
Classification Of Compensation Expense Within Consolidated Statements Of Income	'


	(in thousands)	Three Months Ended				Nine Months Ended
		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013
	Direct costs	$	878	$	531	$	2,212	$	1,310

	Selling, general and administrative	3,034		2,137		8,668		6,793

	Total stock-based compensation	$	3,912	$	2,668	$	10,880	$	8,103

Restructuring_Charges_Tables

Restructuring Charges (Tables)

9 Months Ended

Mar. 31, 2014

Restructuring Charges [Abstract]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

(in thousands)

Balance at

Provisions/

Payments/Foreign

Balance at

June 30, 2013

Adjustments

Currency Exchange

March 31, 2014

Facilities-related charges and other

2,559

(74

)

(700

)

1,785

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Service Revenue, Direct Costs And Gross Profit On Service Revenue Of Reportable Segment	'


	(in thousands)	Three Months Ended				Nine Months Ended
		March 31, 2014		March 31, 2013		March 31, 2014		March 31, 2013
	Service revenue
	CRS	$	373,216	$	342,387	$	1,069,675	$	960,134

	PC	51,880		50,611		160,949		148,236

	PI	67,279		61,495		198,141		162,944

	Total service revenue	$	492,375	$	454,493	$	1,428,765	$	1,271,314

	Direct costs
	CRS	$	255,244	$	246,882	$	748,663	$	709,463

	PC	30,420		30,424		94,909		88,563

	PI	37,485		34,611		107,278		94,620

	Total direct costs	$	323,149	$	311,917	$	950,850	$	892,646

	Gross profit
	CRS	$	117,972	$	95,505	$	321,012	$	250,671

	PC	21,460		20,187		66,040		59,673

	PI	29,794		26,884		90,863		68,324

	Total gross profit	$	169,226	$	142,576	$	477,915	$	378,668

Debt_Commitments_Contingencies1

Debt, Commitments, Contingencies And Guarantees Schedule of Contractual Obligation (Tables)	9 Months Ended
	Mar. 31, 2014
Schedule of Long-term Debt Obligation [Abstract]	'
Schedule of Maturities of Long-term Debt [Table Text Block]	'


	(in thousands)	FY 2014		FY 2015		FY 2016		FY 2017		FY 2018		Thereafter		Total
	Debt obligations (principal)	$	3,033	$	12,500	$	25,000	$	45,000	$	115,000	$	100,000	$	300,533

Derivatives_Tables

Derivatives (Tables)	9 Months Ended
	Mar. 31, 2014
Summary of Derivative Instruments by Hedge Designation [Abstract]	'
Schedule Of Notional Amounts And Fair Values Of Derivatives	'


	(in thousands)	March 31, 2014						June 30, 2013
		Notional			Asset			Notional			Asset
		Amount			(Liability)			Amount			(Liability)
	Derivatives designated as hedging instruments under ASC 815
	Derivatives in an asset position:
	Interest rate contracts	$	100,000		$	2,819		$	125,000		$	3,269

	Foreign exchange contracts	152,178			5,380			20,245			333

	Cross-currency swap contracts	25,760			1,125			27,312			1,032

	Derivatives in a liability position:
	Interest rate contracts	100,000			(1,719		)	100,000			(2,208		)

	Foreign exchange contracts	33,386			(964		)	129,254			(3,889		)

	Total designated derivatives	$	411,324		$	6,641		$	401,811		$	(1,463	)

	Derivatives not designated as hedging instruments under ASC 815
	Derivatives in an asset position:
	Foreign exchange contracts	$	50,016		$	995		$	20,756		$	91

	Derivatives in a liability position:
	Cross-currency interest rate swap contracts	—			—			44,580			(1,910		)

	Foreign exchange contracts	84,822			(429		)	42,800			(992		)

	Total non-designated derivatives	$	134,838		$	566		$	108,136		$	(2,811	)

	Total derivatives	$	546,162		$	7,207		$	509,947		$	(4,274	)

Schedule Of Change In The Fair Value Of Derivatives Designated As Hedging Instruments	'


	(in thousands)	Three Months Ended						Nine Months Ended
		March 31, 2014			March 31, 2013			March 31, 2014			March 31, 2013
	Derivatives designated as hedging instruments under ASC 815
	Interest rate contracts, net of taxes	$	195		$	155		$	152		$	281

	Foreign exchange contracts, net of taxes	10			(1,963		)	(4,987		)	(1,736		)

	Cross-currency swap contracts, net of taxes	(29		)	741			85			338

	Total designated derivatives	$	176		$	(1,067	)	$	(4,750	)	$	(1,117	)

Schedule Of Change In The Fair Value Derivatives Not Designated As Hedging Instruments	'


	(in thousands)	Three Months Ended						Nine Months Ended
		March 31, 2014			March 31, 2013			March 31, 2014			March 31, 2013
	Derivatives not designated as hedging instruments under ASC 815
	Cross-currency interest rate swap contracts	$	3,431		$	2,051		$	1,910		$	1,924

	Foreign exchange contracts	736			(347		)	1,467			87

	Total non-designated derivative unrealized (loss) gain, net	$	4,167		$	1,704		$	3,377		$	2,011

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value	'


	(in thousands)	Level 1				Level 2			Level 3			Total
	Contingent consideration	$	—			$	—		$	(5,934	)	$	(5,934	)

	Interest rate derivative instruments	—				(849		)	—			(849		)

	Foreign currency exchange contracts	—				(3,425		)	—			(3,425		)

	Total	$	—			$	(4,274	)	$	(5,934	)	$	(10,208	)



	(in thousands)	Level 1				Level 2			Level 3			Total
	Contingent consideration	$	—			$	—		$	(5,883	)	$	(5,883	)

	Interest rate derivative instruments	—				1,100			—			1,100

	Foreign currency exchange contracts	—				6,107			—			6,107

	Total	$	—			$	7,207		$	(5,883	)	$	1,324

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]	'


	Unobservable Input		Range
	Discount rate		18%
	Probability of achieving financial targets		10% to 45%
	Projected year of payment		2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'


	(in thousands)		Fair Value
	Balance at June 30, 2013		$	5,934

	Change in fair value related to contingent consideration from HERON acquisition		(51		)
	Balance at March 31, 2014		$	5,883

Basis_Of_Presentation_Details

Basis Of Presentation (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2013
Basis Of Presentation [Abstract]	'	'
Investment Income, Interest	$0.80	$2.90
Interest Expense	$3.40	$8.30

Equity_and_Earnings_Per_Share_1

Equity and Earnings Per Share (Computation Of Basic And Diluted Earnings Per Common Share) (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

15 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Jun. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

September 2012 Accelerated Share Repurchase [Member]

September Open Market Repurchases [Member]

March 2013 Accelerated Share Repurchase [Member]

March Open Market Repurchases [Member]

Class of Stock [Line Items]

Preferred Stock, Shares Authorized

5,000,000

Preferred Stock, Par or Stated Value Per Share

$0.01

Preferred Stock, Shares Outstanding

Common Stock, Shares Authorized

150,000,000

Common Stock, Par or Stated Value Per Share

$0.01

Common Stock, Shares, Outstanding

56,851,510

56,310,582

Disclosure of Repurchase Agreements [Abstract]

Stock Repurchase Program Authorized Amount

$200,000,000

Treasury Stock, Shares, Acquired

5,458,285

101,247

51,071

Treasury Stock, Value, Acquired, Cost Method

2,400,000

197,600,000

200,000,000

50,000,000

Treasury Stock, Value, Acquired, Average Cost Per Share

$36.64

Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]

Net income attributable to common stock

$34,739,000

$29,524,000

$89,022,000

$65,931,000

Weighted average number of shares outstanding, used in computing basic earnings per share

56,713,000

58,024,000

56,494,000

58,942,000

Dilutive common stock equivalents

960,000

1,050,000

992,000

1,063,000

Weighted average number of shares outstanding used in computing diluted earnings per share

57,673,000

59,074,000

57,486,000

60,005,000

Basic earnings per share

$0.61

$0.51

$1.58

$1.12

Diluted earnings per share

$0.60

$0.50

$1.55

$1.10

Anti-dilutive options (excluded from the calculation of diluted earnings per share)

798,000

717,000

439,000

396,000

Comprehensive_Income_Schedule_

Comprehensive Income (Schedule Of Comprehensive Income) (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	($6,882,000)	'	($6,882,000)	'	($29,138,000)
Other comprehensive income before reclassifications	'	'	26,818,000	'	'
Amounts reclassified from accumulated other comprehensive income to earnings, net of tax	'	'	188,000	'	'
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	-686,000	-15,339,000	22,256,000	4,861,000	'
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	-176,000	-1,067,000	4,750,000	-1,117,000	'
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	'	'	27,006,000	'	'
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	3,850,000	'	3,850,000	'	-900,000
Accumulated Other Comprehensive Income (Loss), Net of Tax	-3,032,000	'	-3,032,000	'	-30,038,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	926,000	-1,255,000	-340,000	-1,279,000	'
Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax	400,000	-400,000	-200,000	-500,000	'
Interest Rate Contract [Member]	'	'	'	'	'
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	-440,000	-296,000	-1,308,000	-867,000	'
Foreign Exchange Contract [Member]	'	'	'	'	'
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	1,366,000	-959,000	854,000	-630,000	'
Cross Currency Swap Contracts [Member]	'	'	'	'	'
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	0	0	114,000	218,000	'
Accumulated Translation Adjustment [Member]	'	'	'	'	'
Amounts reclassified from accumulated other comprehensive income to earnings, net of tax	'	'	0	'	'
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]	'	'	'	'	'
Other comprehensive income before reclassifications	'	'	4,562,000	'	'
Amounts reclassified from accumulated other comprehensive income to earnings, net of tax	'	'	$188,000	'	'

StockBased_Compensation_Classi

Stock-Based Compensation (Classification Of Compensation Expense Within Consolidated Statements Of Income) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Share-based Compensation	$3,912	$2,668	$10,880	$8,103
Direct Costs [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Share-based Compensation	878	531	2,212	1,310
Selling, General And Administrative [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Share-based Compensation	$3,034	$2,137	$8,668	$6,793

Restructuring_Charges_Schedule

Restructuring Charges (Schedule Of Charges Against The Restructuring Accrual) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Provisions/Adjustments	($74)	($732)	($74)	($1,150)
Facilities-Related Charges [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Balance at June 30, 2013	'	'	2,559	'
Provisions/Adjustments	'	'	-74	'
Payments/Foreign Currency Exchange	'	'	-700	'
Balance at September 30, 2013	$1,785	'	$1,785	'

Segment_Information_Service_Re

Segment Information (Service Revenue, Direct Costs And Gross Profit On Service Revenue Of Reportable Segment) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Service revenue	$492,375	$454,493	$1,428,765	$1,271,314
Direct costs	323,149	311,917	950,850	892,646
Gross profit	169,226	142,576	477,915	378,668
CRS [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenue	373,216	342,387	1,069,675	960,134
Direct costs	255,244	246,882	748,663	709,463
Gross profit	117,972	95,505	321,012	250,671
PCMS [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenue	51,880	50,611	160,949	148,236
Direct costs	30,420	30,424	94,909	88,563
Gross profit	21,460	20,187	66,040	59,673
Perceptive [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenue	67,279	61,495	198,141	162,944
Direct costs	37,485	34,611	107,278	94,620
Gross profit	$29,794	$26,884	$90,863	$68,324

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Income Tax Holiday [Line Items]	'	'	'	'	'
Gross unrecognized tax benefits	$44.50	'	$44.50	'	$46.60
Gross unrecognized tax benefits that would impact the effective tax rate if recognized	29.2	'	29.2	'	31
Net change in liability for unrecognized tax benefits for uncertain tax positions	'	'	-2.1	'	'
Anticipated liability decrease for unrecognized tax benefits for uncertain tax positions	6.5	'	6.5	'	'
Interest and penalties included in liability for unrecognized tax benefits	6	'	6	'	5
Interest and penalties included in income tax expense	'	'	$0.80	$1	'
Effective income tax rate	30.30%	17.60%	32.40%	30.20%	'

Credit_Agreements_Details

Credit Agreements (Details)

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

3 Months Ended

Mar. 31, 2013

Mar. 31, 2014

Jun. 30, 2013

31-May-13

Mar. 22, 2013

Mar. 31, 2014

Jun. 30, 2013

Mar. 31, 2014

31-May-13

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 22, 2013

Mar. 31, 2014

Mar. 22, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 22, 2013

Mar. 31, 2014

Jul. 25, 2013

Mar. 31, 2014

Jun. 30, 2013

Mar. 31, 2014

USD ($)

JP Morgan [Member]

JP Morgan UK [Member]

RBSNederlandNV [Member]

Interest Rate Cap [Member]

Interest Rate Swap [Member]

Senior Notes due in 2020 [Member]

2013 Credit Agreement LIBOR [Member]

2013 Credit Agreement [Member]

Swingline Loan [Member]

Revolving Credit Facility [Member]

2013 Credit Agreement Federal Funds Rate [Member]

2013 Credit Agreement One Month LIBOR [Member]

2013 Credit Agreement One Month LIBOR Margin [Member]

2013 Credit Agreement Swingline [Member]

Term Loan [Member]

Senior Notes due in 2020 [Member]

Designated as Hedging Instrument [Member]

USD ($)

EUR (€)

USD ($)

Senior Notes [Member]

USD ($)

Interest Rate Contract [Member]

USD ($)

Line of Credit Facility [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

3.11%

Derivative, Notional Amount

$546,162,000

$509,947,000

$411,324,000

$401,811,000

$200,000,000

Deferred Finance Costs, Noncurrent, Net

400,000

2,900,000

Long-term Debt

200,000,000

Debt Instrument, Face Amount

200,000,000

Proceeds from Issuance of Long-term Debt

107,500,000

Line of Credit Facility, Current Borrowing Capacity

75,000,000

300,000,000

Letters of Credit Outstanding, Amount

10,200,000

10,000,000

Debt Instrument, Basis Spread on Variable Rate

1.75%

0.50%

1.00%

0.75%

Term Loan, Quarterly Principal Payment Percentage,year one and two

1.25%

Term Loan, Quarterly Principal Payment Percentage,year three

2.50%

Term Loan, Quarterly Principal Payment Percentage,year four

5.00%

Term Loan, Quarterly Principal Payment Percentage,year five

7.50%

Term Loan, Quarterly Principal Payment Percentage,maturity date

37.50%

Credit agreement maximum borrowing capacity

4,500,000

5,000,000

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum

2.00%

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum

4.00%

Line of credit facility amount outstanding

10,000,000

Long-term Debt, Gross

300,533,000

190,000,000

100,000,000

Max commitment fee on revolving loan unused amount, percentage

0.35%

Remaining borrowing available under revolving credit facility

4,500,000

5,000,000

290,000,000

Interest rate swap, fixed interest rate

1.30%

0.73%

Derivative interest rate cap arrangement

2.00%

Principal amount of debt hedged with an interest rate swap agreement

25,000,000

100,000,000

Debt, Weighted Average Interest Rate

0.00%

Transfers of Financial Assets Including Debt Activity

122,900,000

Other Short-term Borrowings

$500,000

$10,400,000

Debt_Commitments_Contingencies2

Debt, Commitments, Contingencies And Guarantees Schedule of Contractual Obligation (Details) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Contractual Obligation [Abstract]	'
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months	$3,033
Long-term Debt, Maturities, Repayments of Principal in Year Two	12,500
Long-term Debt, Maturities, Repayments of Principal in Year Three	25,000
Long-term Debt, Maturities, Repayments of Principal in Year Four	45,000
Long-term Debt, Maturities, Repayments of Principal in Year Five	115,000
Long-term Debt, Maturities, Repayments of Principal after Year Five	100,000
Long-term Debt, Gross	$300,533

Commitments_Contingencies_And_

Commitments, Contingencies And Guarantees (Details) (USD $)	Mar. 31, 2014
In Millions, unless otherwise specified	Mar. 31, 2014
Commitments, Contingencies And Guarantees [Abstract]	'
Letters of Credit Outstanding, Amount	$10.20

Derivatives_Schedule_Of_Notion

Derivatives (Schedule Of Notional Amounts And Fair Values Of Derivatives) (Details) (USD $)	Mar. 31, 2014	Jun. 30, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Jun. 30, 2013
Derivatives, Fair Value [Line Items]	'	'
Notional Amount	$546,162	$509,947
Asset (Liability)	7,207	-4,274
Derivatives Not Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional Amount	134,838	108,136
Asset (Liability)	566	-2,811
Derivatives Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional Amount	411,324	401,811
Asset (Liability)	6,641	-1,463
Interest Rate Contract [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional Amount	200,000	'
Derivative Liability, Fair Value, Gross Liability	-1,719	-2,208
Derivative Asset, Fair Value, Gross Asset	2,819	3,269
Derivative Liability, Notional Amount	100,000	100,000
Derivative Asset, Notional Amount	100,000	125,000
Cross Currency Swap Contracts [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	1,125	1,032
Derivative Asset, Notional Amount	25,760	27,312
Cross-Currency Interest Rate Swap Contracts [Member] \| Derivatives Not Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative Liability, Fair Value, Gross Liability	0	-1,910
Derivative Liability, Notional Amount	0	44,580
Foreign Exchange Contracts [Member] \| Derivatives Not Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative Liability, Fair Value, Gross Liability	-429	-992
Derivative Asset, Fair Value, Gross Asset	995	91
Derivative Liability, Notional Amount	84,822	42,800
Derivative Asset, Notional Amount	50,016	20,756
Foreign Exchange Contracts [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative Liability, Fair Value, Gross Liability	-964	-3,889
Derivative Asset, Fair Value, Gross Asset	5,380	333
Derivative Liability, Notional Amount	33,386	129,254
Derivative Asset, Notional Amount	$152,178	$20,245

Derivatives_Schedule_Of_Change

Derivatives (Schedule Of Change In The Fair Value Of Derivatives Designated As Hedging Instruments) (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	$200,000	($700,000)	$3,100,000	($700,000)
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	200,000	-500,000	0	-400,000
Estimated net amount of existing losses that are expected to be reclassified into earnings	'	'	3,300,000	'
Derivatives Designated As Hedging Instruments [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative instruments, gain (loss) recognized in other comprehensive income, effective portion, net, total	176,000	-1,067,000	-4,750,000	-1,117,000
Interest Rate Contract [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative instruments, gain (loss) recognized in other comprehensive income, effective portion, net, total	195,000	155,000	152,000	281,000
Foreign Exchange Contracts [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative instruments, gain (loss) recognized in other comprehensive income, effective portion, net, total	10,000	-1,963,000	-4,987,000	-1,736,000
Cross Currency Swap Contracts [Member] \| Derivatives Designated As Hedging Instruments [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative instruments, gain (loss) recognized in other comprehensive income, effective portion, net, total	($29,000)	$741,000	$85,000	$338,000

Derivatives_Schedule_Of_Change1

Derivatives (Schedule Of Change In The Fair Value Of Derivatives Not Designated As Hedging Instruments) (Details) (Derivatives Not Designated As Hedging Instruments [Member], USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Fair value of derivatives not designated as hedging instruments	$4,167	$1,704	$3,377	$2,011
Foreign Exchange Contracts [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Fair value of derivatives not designated as hedging instruments	736	-347	1,467	87
Cross-Currency Interest Rate Swap Contracts [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Fair value of derivatives not designated as hedging instruments	$3,431	$2,051	$1,910	$1,924

Fair_Value_Measurements_Schedu

Fair Value Measurements (Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value) (Details) (USD $)	9 Months Ended								3 Months Ended
	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2013	Jun. 30, 2013	1-May-13
	Mar. 31, 2014	Jun. 30, 2013	Fair Value, Inputs, Level 1 [Member]	Fair Value, Inputs, Level 1 [Member]	Fair Value, Inputs, Level 2 [Member]	Fair Value, Inputs, Level 2 [Member]	Fair Value, Inputs, Level 3 [Member]	Fair Value, Inputs, Level 3 [Member]	Heron Acquisition [Member]	Heron Acquisition [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'	'	'	'	'	'	'	'	'
Business Acquisition, Cost of Acquired Entity, Cash Paid	'	'	'	'	'	'	'	'	$22,800,000	'
Business Acquisition, Contingent Consideration, Potential Cash Payment	'	'	'	'	'	'	'	'	'	14,200,000
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value	5,883,000	5,934,000	'	'	'	'	'	'	'	'
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	-51,000	'	'	'	'	'	'	'	'	'
Long-term Debt, Fair Value	94,900,000	'	'	'	'	'	'	'	'	'
Fair Value Inputs, Discount Rate	18.00%	'	'	'	'	'	'	'	'	'
Interest Rate Derivative Instruments	1,100,000	-849,000	0	0	1,100,000	-849,000	0	0	'	'
Foreign Currency Exchange Contracts	6,107,000	-3,425,000	0	0	6,107,000	-3,425,000	0	0	'	'
Total	1,324,000	-10,208,000	0	0	7,207,000	-4,274,000	-5,883,000	-5,934,000	'	'
Marketable Securities, Current	0	130,137,000	'	'	'	'	'	'	'	'
Business Acquisition, Contingent Consideration, at Fair Value	($5,883,000)	($5,934,000)	$0	$0	$0	$0	($5,883,000)	($5,934,000)	'	($5,900,000)